Hundreds of thousands people are expected to be booted off the state-run health insurance program over the next year as federal continuous coverage requirements for Medicaid in place since March 2020 expire and the state goes through the required redetermination process for the first time since the pandemic began.
Marlborough medical device company Candela Corp. has received clearance from the U.S. Food & Drug Administration to use the company’s laster system to treat Melasma, a skin condition frequently arising during pregnancy, among other times.
UMass Chan Medical School is consolidating its workforce at MassBiologics, its Boston-based biologics and vaccine manufacturing arm. The affected positions will be eliminated in 60 days.
People are on the move at the Family Health Center of Worcester, AdCare Hospital in Worcester, the Worcester law firm Bowditch & Dewey, the Estate Preservation Law Offices, MutualOne Bank in Framingham, Framingham State University, and UMass Memorial Health in Worcester.
Oligo Factory, a Holliston-based biomanufacturer, opened Thursday a new 13,000 square foot facility to scale-up its production processes. The new facility will serve as Oligo’s new headquarters and will increase manufacturing capabilities for the company by a factor of 12.
Worcester insurtech firm Xceedance is among a consortium of investors to provide $4.1 million to Vitraya Technologies, a blockchain company based in Punjab, India.
Boston developer Synergy Investments, which owns The Glass Tower at 446 Main Street has purchased two more Worcester office buildings, including another high rise, at One and Two Chestnut Place for $10.5 million.
UMass Memorial Health has appointed Dr. Lynda Young as board chair and Elvira Guardiola as vice chair of the board of trustees. Young is the first woman to be chair, and Guardiola is the first woman and the first Latina to be vice chair.